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Molecular Genetics Minireview
of Demyelination:
New Wrinkles on an Old Membrane
Steven S. Scherer into question the common assumption that the layers
of the myelin sheath have a high electrical resistance.Department of Neurology
The University of Pennsylvania Medical Center The resistance may actually be low, as has been shown
in the CNS myelin surrounding the Mauthner axon inPhiladelphia, Pennsylvania 19104–6077
goldfish (Funch and Faber, 1984).
What Are the Functions of theThe Structure and Function of Myelin
Myelin is one of the fundamental adaptations of verte- Myelin Components?
While the individual components may normally functionbrates. By limiting axonal depolarization to nodes of
Ranvier, the periodic interruptions in myelin, it increases as part of the macromolecular structure of compact
myelin, they have been examined in isolation. The func-axonal conduction velocity. Its multilamellar structure
results from the spiral wrapping of specialized cell mem- tion of protein zero (P0), the main intrinsic membrane
protein of mammalian PNS myelin, is the best under-brane around an axon (Figure 1A). The apposed external
surfaces of the membrane form the intraperiod lines, stood. It has a single extracellular IgG-like domain and
a basic cytoplasmic domain that have been proposedand the cytoplasmic proteins form the major dense line.
These alternating intraperiod and major dense lines give to hold together, respectively, theextra- and intracellular
surfaces of compact myelin. X-ray crystallography re-myelin its characteristic appearance in electron micro-
graphs (Figure 1B). vealed that P0 has an overall structure that is similar to
other members of the immunoglobulin superfamily, andTwo distinct cell types form myelin, oligodendrocytes
in the CNS and Schwann cells in the PNS, and the com- that the extracellular domain of P0 forms tetramers, with
four molecules arranged around a central hole (Shapiropact myelin that each produces is structurally similar
but chemically distinct (Figure 2). CNS and PNS myelin et al., 1996). Assuming that P0 also forms tetramers in
the plane of the cell membrane, these tetramers mayconsist mostly of lipids, including cholesterol, glycolip-
ids, and specific and overlapping sets of proteins. These interact with their counterparts on the apposing cell
membrane, forming a lattice that holds the apposedcomponents are so highly enriched that myelin has been
likened to a liquid crystal, in which individual compo- extracellular surfaces together. The basic cytoplasmic
domain may bind to intracellular anionic lipids, therebynents form macromolecular complexes with themselves
and each other. Such an orderly structure could require holding the intracellular surfaces together. Since P0 is
an immunoglobulin superfamily member and is found ina precise stoichiometric relationship of the individual
components, so that either increasing or decreasing the CNS and PNS myelin of fishes, it appears that this cell
adhesion molecule was co-opted 500 million years agoamount of one component could result in demyelination
because it perturbs the entire structure. to hold together the myelin sheath.
DM-20 is also an ancient molecule, as homologs havePNS myelin also contain incisures, funnel-shaped do-
mains of noncompact myelin that traverse the compact been found in fishes and amphibians (Yoshida and Col-
man, 1996). It belongs to a family of proteins with fourmyelin sheath and contain bits of cytoplasm. Incisures
have been largely neglected because they had no known transmembrane domains, and proteolipid protein (PLP)
is thought to have arisen from DM-20 by the insertionfunction. Recent work, however, has revealed that the
membranes of incisures and paranodes are similar to of 105 nucleotides encoding 35 amino acids of the cyto-
plasmic loop (Nave and Boespflug-Tanguy, 1996). PLPeach other and contain different proteins than compact
myelin (Figure 2), as well as a6b4 integrin, tight junctions, is the main intrinsic membrane protein in mammalian
CNS myelin and probably originated in amphibians. PLPadherens junctions, and gap junctions (Scherer, 1996).
While these junctions are classically described between and DM-20 are highly conserved, indicating that they
have a critically important function in myelinating glia.apposed cells in various epithelia, they link apposed
surfaces of the same cell in the PNS myelin sheath. Tight However, this function has remained elusive; it is possi-
ble that these proteins are homophilic adhesion mole-junctions may separate the paranodes and incisures
from extracellular space. Adherens junctions contain cules and/or form ion channels across the lipid bilayer.
Like DM-20, peripheral myelin protein 22 kDa (PMP22)E-cadherin and link consecutive layers of the myelin
sheath together. By forming a radial pathway for ions is predicted to have four transmembrane domains. It is
closely related to two other proteins (Taylor and Suter,and small molecules, gap junctions could reduce the
diffusion distance of small molecules and ions up to 1996) and possibly related to a newly described protein
expressed by oligodendrocytes (Bronstein et al., 1996).1000-fold, as compared to the circumferential pathway
within the Schwann cell cytoplasm. The importance of In spite of its importance in the pathogenesis of inherited
demyelinating neuropathies, its function is still uncertainthis radial pathway is underscored by the finding that
mutations in the gap junction protein connexin32 (Cx32), (Suter and Snipes, 1995). Before its role as a myelin
protein was known, PMP22 had been described as awhich is localized to incisures and paranodes, cause
the X-linked form of Charcot-Marie-Tooth (CMT) disease growth-arrest protein in fibroblasts and appears to have
similar effects in cultured Schwann cells. The ability of(Suter and Snipes, 1995). This radial pathway also calls
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Table 1. The Relationship of Mutations in Myelin-Related Genes
to Inherited Demyelinating Diseases
Gene CNS PNS Mouse mutant Human disease
PLP 1 2 jp, jpmsd, jprsh Pelizaeus-Merzbacher
knockout disease
overexpressing hereditary spastic
transgenic paraparesis
MBP 1 1 sh ?
PMP22 2 1 Tr, TrJ CMT1A
knockout HNPP
overexpressing Dejerine-Sottas disease
transgenic
P0 2 1 knockout CMT1B
Dejerine-Sottas disease
Cx32 1 1 knockout CMTXFigure 1. Ultrastructure of a Myelinated Fiber From a 5-Day-Old
mag 1 1 knockout ?Mouse Sciatic Nerve
cgt 1 1 knockout ?(A) An axon (a), its myelin sheath (m), Schwann cell nucleus (n), and
basal lamina (arrowheads). Scale bar, 0.5 mm.
(B) Compact myelin is composed of alternating major dense lines
(arrows) and interperiod lines; the distance between the major dense
more than a simple loss of function can be attributed tolines is 15 nm.
dominant–negative interactions (the mutation interferes
with the product of the normal allele) or toxic effects
(the mutation has a deleterious effect on the cell).PMP22 to cause growth-arrest, however, may be unre-
lated to how PMP22 mutations cause neuropathy, as PMP22 and P0
Mutations in these genes in humans cause dominantlyoverexpression of PMP22 in vivo causes excessive pro-
liferation of Schwann cells, not growth arrest (Magyar inherited forms of demyelinating CMT (CMT1A and
CMT1B), as well as other forms of demyelinating neuro-et al., 1996; Sereda et al., 1996).
pathy that differ so remarkably in severity that they have
traditionally been classified as distinct diseases (TableMutations in Myelin-Related Genes
Cause Demyelination 1). The most common inherited neuropathies are CMT1A
and hereditary neuropathy with liability to pressure pal-A robust interaction between the investigations of my-
elin and inherited demyelinating diseases of mice and sies (HNPP), which are caused by the duplication and
deletion, respectively, of a 1.5 Mb segment of chromo-humans has led to the discovery of the molecular basis
of these diseases (reviewed by Suter and Snipes, 1995). some 17 containing PMP22 (Suter and Snipes, 1995).
Overexpressing or underexpressing the PMP22 geneAfter myelin was shown to contain PLP, myelin basic
protein (MBP), and PMP22, naturally occurring muta- alone causes demyelination in rodents, demonstrating
that PMP22 is the critical gene in the 1.5 Mb segmenttions of their genes were shown to cause respectively
the jimpy (jp), shiverer (sh), and Trembler (Tr) mutations (Magyar et al., 1996; Sereda et al., 1996). Consistent
with the changes in gene dosage, the amount of PMP22in mice, and subsequently human diseases (Table 1). In
mice these naturally occurring mutations have now been protein in compact myelin is increased in CMT1A and
decreased in HNPP (Vallat et al., 1996) , indicating thataugmented by gene “knockouts,” which are particularly
valuable as the targeting vector typically creates a loss- altered levels of PMP22 destabilize the myelin sheath.
Missense mutations in PMP22 are rare, and the resultantof-function allele. The reason that these null alleles are
so important relates to the following argument: if the phenotypes are typically much more severe than in
HNPP, ranging from typical CMT1 to even more severephenotype caused by a null allele is milder than that
caused by another allele, then the latter must cause forms (Dejerine-Sottas disease).
Warner et al. (1996) argue that P0 mutations in humansmore than a simple loss of function. Such comparisons
can be directly made in murine mutations of Pmp22 cause demyelination because they adversely affect the
function of P0 as an adhesion molecule. They postulateand Plp; the same reasoning can be applied to human
mutations of PMP22, PLP, and P0. How mutations cause that mutations that result in a simple loss of function
Figure 2. Localization of Myelin Components
in the Mammalian CNS and PNS Myelin
Sheaths
Noncompact myelin is found at the para-
nodes in the mammalian CNS, but it lacks
some of the molecular specializations found
in noncompact myelin of the PNS myelin,
such as MAG and E-cadherin. Although MAG
is illustrated as interacting homophilically,
this is unproven.
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cause CMT1B, whereas mutations that alter the ability chief manifestation is spasticity of the legs. As in mice,
PLP deletions in humans result in a milder phenotypeof P0 to interact with other P0 molecules cause more
severe phenotypes owing to dominant–negative effects. than most missense mutations, and missense mutations
that affect less conserved residues tend to cause aThe problem with their interpretation is that the patients
affected by their best example of a loss-of-function mu- milder phenotype. The deleterious effect of these mis-
sense mutations, furthermore, is toxic; it cannot betation (a premature truncation of the extracellular do-
main) have a milder phenotype than any other CMT1B caused by dominant–negative interactions in the usual
sense because each cell (even in females) expressespatient. Because other CMT1B patients have a much
more severe phenotype, the responsible mutations only a single PLP gene.
These observations have been extended to a cellularprobably cause more than a simple loss of function.
Further, the range of phenotypes in different kindreds level by expressing various PLP mutants and their DM-
20 counterparts separately in COS-7 cells (Gow andsuggests that different P0 mutations may have distinct
effects. Dominant–negative interactions of P0 mutations Lazzarini, 1996). Both PLP and DM-20 fail to reach
the cell surface when PLP (human) and Plp (mouse)have been demonstrated (Wong and Filbin, 1996), but
other explanations, such as the misfolding of the mu- mutations causing severe phenotypes are expressed,
whereas DM-20 but not PLP reaches the cell surfacetated protein, have not been evaluated.
The analysis of P02/2 and P01/2 mice is also consistent when PLP and Plp mutationscausing milder phenotypes
are expressed. When DM-20 and PLP do not reach thewith an adhesive role of P0. Myelinating Schwann cells
in P02/2 mice form a multilamellar myelin-like sheath cell surface, they accumulate in the endoplasmic reticu-
lum; this could be the basis for the toxic gain of functionaround axons, but the myelin fails to compact normally.
Myelination in P01/2 mice, in contrast, is essentially nor- of these mutants. These results also suggest that the
ability of DM-20 to accumulate in myelin may be criticalmal for several months, but aging animals develop a
demyelinating neuropathy. Thus, a single P0 allele allows to reducing the severity of the phenotype.
Cx32myelin to compact normally during development but
appears to be insufficient to maintainmyelin compaction CMTX is distinct from CMT1 and is caused by mutations
of the gene encoding the gap junction protein Cx32through adulthood.
Plp (Suter and Snipes, 1995). Nearly 90 different mutations
in Cx32 cause CMTX, and in most kindreds, the diseaseThe first clue that missense Plp mutations cause more
than a loss of function was the realization that different is X-linked dominant, with males affected earlier and
more severely than females. The range of phenotypesjp alleles cause phenotypes of varying severity (Nave
and Boespflug-Tanguy, 1996). The jp and jpmsd alleles is not nearly as dramatic as in other inherited demyelin-
ating diseases, but frame–shift mutations and some pre-cause a severe phenotype: many oligodendrocytes un-
dergo apoptosis, little myelin is produced, and the ani- mature truncations may cause more severe phenotypes.
The functional effects of a few mutations have beenmals die at a young age. The phenotype of jprsh, in con-
trast, is relatively mild: oligodendrocytes do not die, a determined by expressing them in Xenopus oocytes and
HeLa cells, which are standard assay systems for thissignificant amount of myelin is produced, and the ani-
mals are long-lived. Initially, the basis for these different purpose (Bruzzone et al., 1996; Omori et al., 1996). Most
Cx32 mutants tested to date do not form functionalphenotypes was unclear. The jpmsd mutation affects a
residue that is highly conserved in other DM-20 family gap junctions with wild-type Cx32, indicating that these
mutations cause a loss of Cx32 function. Immaturemembers, whereas the jprsh mutation affects a less con-
served residue, so that more severe phenotypes might Cx322/2 mice have normal-appearing myelin but de-
velop a demyelinating neuropathy with age (Nelles etowe to a more complete loss of function. In this case,
a PLP transgene should rescue the phenotype of jp al., 1996), demonstrating that a loss-of-function allele is
sufficient to cause demyelination. Some mutants, how-mice. This was not observed, indicating that severe phe-
notypes probably represent instead a dominant, delete- ever, can form functional gap junctions, so it is unclear
how they could cause demyelination. One possible ex-rious effect of Plp mutations. The analysis of Plp2/2 mice
provides a more rigorous proof, as these mice have a planation is that these Cx32 mutants have dominant–
negative interactions with other connexins, as has beenmild to minimal phenotype (Boison and Stoffel, 1994;
Klugmann et al., 1997 [this issue]). The mice are fertile demonstrated in oocytes. It remains to be demonstrated
that myelinating Schwann cells express other membersand long-lived, although CNS myelin is poorly com-
pacted and has an abnormal periodicity, perhaps re- of the connexin family, and that Cx32 mutants have
dominant-negative interactions with them.flecting reduced adhesion between the extracellular sur-
faces in the absence of PLP. UDP-galactose ceramide galactosyltransferase (cgt)
The targeted disruption of cgt provides the unprece-Missense PLP mutations in humans also cause a wide
range of abnormalities, mainly seen in males, as the PLP dented opportunity to perturb the lipid components of
myelin (Bosio et al., 1996; Coetzee et al., 1996). Becausegene is on the X chromosome (Nave and Boespflug-
Tanguy, 1996). The connatal form of Pelizaeus-Merz- CGT is necessary for the synthesis of Gal-C and sul-
fatide, these glycolipids are completely absent in cgt2/2bacher disease (PMD) is the most severe; affected males
have severe psychomotor impairment and typically die mice, although the levels of glucoceramides are ele-
vated. cgt2/2 mice develop neurological signs with thebefore 10 years of age. Males affected with the classical
form of PMD, in contrast, have much milder motor and onset of myelination, and most die between 18 and 30
days. Surprisingly, except for the splitting of some CNSintellectual defects as well as longer lives. The mildest
phenotype is spastic paraplegia, so named because the myelin sheaths, most CNS and PNS myelinsheaths have
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Suter, U., and Snipes, G.J. (1995). Annu. Rev. Neurosci. 18, 45–75.a normal ultrastructure. In spite of this normal appear-
Taylor, V., and Suter, U. (1996). Gene 175, 115–120.ance, axonal conduction velocity is dramatically slowed;
Vallat, J.M., Sindou, P., Preux, P.M., Tabaraud, F., Milor, A.M., Cour-in the PNS, the conduction velocity is only slightly
atier, P., Leguern, E., and Brice, A. (1996). Ann. Neurol. 39, 813–817.greater than that expected for unmyelinated axons of
Warner, L.E., Hilz, M.J., Appel, S.H., Killian, J.M., Watters, G.V.,comparable caliber. While the electrophysiological
Wheeler, C., Witt, D., Bodell, A., Nelis, E., Van Broeckhoven, C., andproperties of these myelin membranes have not been
Lupski, J.R. (1996). Neuron 17, 451–460.directly measured, one possible explanation is that lack
Wong, M.H., and Filbin, M.T. (1996). J. Cell Biol. 134, 1531–1541.of Gal-C and sulfatide increases the capacitance of the
Yoshida, M., and Colman, D.R. (1996). Neuron 16, 1115–1126.myelin, leading to a normal-appearing but functionless
myelin sheath.
Wrapping Up
The study of myelin and inherited demyelinating disor-
ders has converged to a common point: the biology of
myelin-forming cells. Once the subject of a lively debate,
all of the known mutations causing demyelination have
turned out to affect genes expressed by myelin-forming
cells; mutations of neuronal genes have not yet been
shown to cause any inherited demyelinating disease.
The consequences of these mutations, moreover, must
ultimately be deciphered in the myelinating cells. This
will be challenging, given the large number of genes that
cause demyelination, the different effects of mutations
that have been described, the sheer number of muta-
tions, and the possibility of macromolecular interactions
in the myelin sheath. Yet, determining the molecular
mechanisms of demyelination is a powerful way to un-
derstand the function of myelin and the clearest way to
a rational basis for classifying and treating these dis-
orders.
Selected Reading
Boison, D., and Stoffel, W. (1994). Proc. Natl. Acad. Sci. USA 91,
11709–11713.
Bosio, A., Binczek, E., and Stoffel, W. (1996). Proc. Natl. Acad. Sci.
USA 93, 13280–13285.
Bronstein, J.M., Popper, P., Micevych, P.E., and Farber, D.B. (1996).
Neurology 47, 772–778.
Bruzzone, R., White, T.W., and Paul, D.L. (1996). Eur. J. Biochem.
238, 1–27.
Coetzee, T., Fujita, N., Dupree, J., Shi, R., Blight, A., Suzuki, K.,
Suzuki, K., and Popko, B. (1996). Cell 86, 209–219.
Funch, P.G., and Faber, D.S. (1984). Science 225, 538–540.
Gow, A., and Lazzarini, R.A. (1996). Nat. Genet. 13, 422–427.
Klugmann, M., Schwab, M.H., Pu¨hlofer, A. Schneider A., Zimmer-
mann, F., Griffiths, I.R., and Nave R.-A. (1997). Neuron 18, this issue.
Magyar, J.P., Martini, R., Ruelicke, T., Aguzzi, A., Adlkofer, K., Dem-
bic, Z., Zielasek, J., Toyka, K.V., and Suter, U. (1996). J. Neurosci.
16, 5351–5360.
Nave, K.-A., and Boespflug-Tanguy, O. (1996). Neuroscientist 2,
33–43.
Nelles, E., Butzler, C., Jung, D., Temme, A., Gabriel, H.-D., Dahl, U.,
Traub, O., Stumpel, F., Jungermann, K., Zielasek, J., Toyka, K.V.,
Dermietzel, R., and Willecke, K. (1996). Proc. Natl. Acad. Sci. USA
93, 9565–9570.
Omori, Y., Mesnil, M., and Yamasaki, H. (1996). Mol. Biol. Cell 7,
907–916.
Scherer, S.S. (1996). Microsc. Res. Tech. 34, 452–461.
Sereda, M., Griffiths, I., Pu¨hlhofer, A., Stewart, H., Rossner, M.J.,
Zimmermann, F., Magyar, J.P., Schneider, A., Hund, E., Meinck,
H.M., Suter, U., and Nave, K.-A. (1996). Neuron 16, 1049–1060.
Shapiro, L., Doyle, J.P., Hensley, P., Colman, D.R., and Hendrickson,
W.A. (1996). Neuron 17, 435–449.
